Merck (MRK) is set to acquire roughly $30M worth of shares of Eikon Therapeutics (EIKN), a cancer-focused biotech ... San Antonio entrepreneur agrees to ...
News
- Merck reportedly eyeing $30M stake in Eikon Therapeutics' IPO - MSN
- New Data Demonstrate CD47 Expression Level Helps Predict Response to ALX Oncology's ...
("ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology ... The primary trial results, presented at the 2024 San Antonio Breast ...
- Gut Feeling: Analytical Chemistry's Role in Measuring and Modeling the Gut - News-Medical
In this region, a growing biotechnology and biomedical ... This collaborative energy is especially evident at events such as Pittcon 2026 in San Antonio ...
- Stockton CTE Programs Hit by Cuts; AB 401 Offers Fix - Hoodline
For Stockton students and the teachers who run its shop classes, culinary labs, and biomedical ... SAN ANTONIO SAN DIEGO SEATTLE TAMPA WASHINGTON, D.C..
- The downside to some cheaper health care alternatives | TPR - Texas Public Radio
Bioscience-Medicine · Border & Immigration · Economy & Business · Crime ... Rep. Joaquin Castro at the steps of San Antonio City Hall on Wed. Jan.